BACKGROUND New renal biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) show promise in early diagnosis of contrast media induced acute kidney injury (CI-AKI). The purpose of our study was to compare the subclinical nephrotoxicity (a condition without changes in standard renal biomarkers) of gadolinium-based contrast media (Gd-DTPA, gadopen...

T administration of contrast agents is usually associated with a few side effects, such as anaphylactoid reaction, heart failure, arrhythmia, renal failure, and encephalopathy. Although non-ionic agents are far less neurotoxic, they have pharmacological side effects, such as seizure, transient cortical blindness, aphasia, and sensory deficit, confusion, short-term memory loss, mental aberration...

OBJECTIVE We aimed to investigate the effectiveness and radiation protection capability of latex gloves coated with various contrast agents as an alternative to lead gloves. METHODS The following six groups were created to evaluate the permeability of X-ray in this experimental study: lead gloves, two different non-ionic contrast media (iopromide 370/100 mg I/mL and iomeprol 400/100 mg I/mL),...

ULTRAVIST (iopromide) Injection is a radiographic contrast agent indicated for:  Cerebral arteriography and peripheral arteriography (300 mg I/mL) (1.1)  Coronary arteriography and left ventriculography, visceral angiography and aortography (370 mg I/mL) (1.1)  Peripheral venography (240 mg I/mL) (1.2)  Excretory urography (300 mg I/mL) (1.2)  Contrast computed tomography (CT) imaging of h...

Among the main restrictions for the implementation of advanced oxidation processes (AOPs) for removal of micropollutants present in reverse osmosis (RO) brines of secondary effluents account the quenching performed by background organic and inorganic constituents. Natural organic matter (NOM) and soluble microbial products (SMP) are the main effluent organic matter constituents. The inorganic f...

We aimed to determine the characteristic adverse events (AEs) of iodinated contrast media (IOCM) and to compare the safety profiles of different IOCM. This study used the database of AEs reports submitted by healthcare professionals from 15 Regional Pharmacovigilance Centers between June 24, 2009 and December 31, 2010 in Korea. All reports of IOCM, including iopromide, iohexol, iopamidol, iomep...